You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
  1. PLASMA & BIOTHERAPIES - 17-12-2016

    IVIg efficacy in chronic inflammatory polyradiculoneuropathy (CIDP)

    Continuous support by Kedrion Biopharma to research and partnering patient associations

    read more 
  2. PLASMA & BIOTHERAPIES - 12-12-2016

    German donors expand patient access to life-saving, plasma-derived therapies

    In Germany KEDPLASMA operates four state-of-the-art plasma collection centers

    read more 
For more information please contact: [email protected]